Lung Cancer
Description
Reviews / Votes
"With almost half of the revised and updated content beingbrand new, Lung Cancer, Fourth Edition, is an important and vitalresource for all medical professionals and students involved in thecare and treatment of those struck with this catastrophicillness." (Kingbook73's Medical Ebook and VideoCollection, 19 September 2014)More details
Other editions
Additional editions
Previous edition
Persons
Content
Contributors, viii
Preface, xiii
1 Smoking Prevention and Cessation, 1
Alexander V. Prokhorov and Karen Suchanek Hudmon
2 Lung Cancer Susceptibility and Risk Assessment Models, 25
Xifeng Wu, Xia Pu, and Jie Lin
3 Molecular Profiling, 48
Lauren Averett Byers
4 Somatic Genome Alterations in Human Lung Cancers, 67
Marcin Imielinski, Peter S. Hammerman, Roman Thomas, and Matthew Meyerson
5 Serum Proteomic Biomarkers, 90
Mohamed Hassanein and David P. Carbone
6 Molecular Biology of Lung Preneoplasia, 110
Humam Kadara and Ignacio I. Wistuba
7 Detection and Treatment of Preneoplastic Lesions, 129
Rachel Jen and Stephen Lam
8 Pathology of Adenocarcinoma, 144
William D. Travis
9 Management of Multifocal Bronchioloalveolar Carcinoma (BAC), 158
Howard West
10 Radiology and Lung Cancer Screening, 176
Patricia de Groot and Reginald F. Munden
11 Imaging Lung Cancer, 191
Sonia L. Betancourt Cuellar, Edith M. Marom, and Jeremy J. Erasmus
12 Staging of the Mediastinum, 202
Mauricio Pipkin and Shaf Keshavjee
13 Management of the Solitary Pulmonary Nodule, 214
Min P. Kim
14 Minimally Invasive Resections for Lung Cancer, 224
Shanda H. Blackmon
15 Extended Resections for Lung Cancer, 236
Matthew A. Steliga and David C. Rice
16 Bronchoscopic Interventions for Lung Cancer, 253
Donald R. Lazarus and George A. Eapen
17 Primary Tracheal Tumors, 267
Francesco Sammartino and Paolo Macchiarini
18 Adjuvant Chemotherapy Following Surgery for Lung Cancer, 278
Kathryn A. Gold
19 Neoadjuvant Chemotherapy for Resectable Non-Small Cell Lung Cancer, 290
Christopher G. Azzoli and Katherine M.W. Pisters
20 Image-Guided Radiation Therapy, 309
Kenneth E. Rosenzweig and Sonal Sura
21 Stereotactic Ablative Radiotherapy for Lung Cancer, 320
Puneeth Iyengar and Robert D. Timmerman
22 Proton Therapy, 338
Joe Y. Chang and James D. Cox
23 Combinations of Radiation Therapy and Chemotherapy for Non-small Cell and Small-Cell Lung Carcinoma, 353
Daniel Gomez, Zhongxing Liao, Pierre Saintigny, and Ritsuko U. Komaki
24 Individualized Radiotherapy by Dose Escalation and Altered Fractionation in Non-small Cell Lung Cancer, 379
Heath D. Skinner, Ritsuko U. Komaki, Joe Y. Chang, and James D. Cox
25 Molecular Target Treatment for Personalized Radiotherapy in Lung Cancer, 390
Steven H. Lin and Ritsuko U. Komaki
26 EGFR Tyrosine Kinase Inhibitors and Monoclonal Antibodies: Clinical Trial Review, 406
Kathryn F. Mileham, Edward S. Kim, and William N. William Jr
27 Mechanisms of Resistance to Epidermal Growth Factor Receptor (EGFR) in Non-small Cell Lung Cancer, 421
Erminia Massarelli
28 Predictive Tumor Biomarkers for EGFR Inhibitors, 435
Lucia Kim, Geoffrey Liu, and Ming-Sound Tsao
29 Immunologic Approaches to Lung Cancer Therapy, 454
Jay M. Lee, Steven M. Dubinett, and Sherven Sharma
30 Novel and Emerging Agents in NSCLC, 464
Anne S. Tsao and Jack A. Roth
31 Novel Clinical Trial Designs for Metastatic Lung Cancer, 479
Vassiliki A. Papadimitrakopoulou
32 Novel Statistical Models for NSCLC Clinical Trials, 488
J. Jack Lee and Caleb T. Chu
33 Tumor Microenvironment, Angiogenesis Biology, and Targeted Therapy, 505
John V. Heymach and Tina Cascone
34 Anti-angiogenic Agents in Metastatic NSCLC, 527
Millie Das and Heather Wakelee
35 Targeting ALK Rearrangements, 541
Justin F. Gainor and Alice T. Shaw
36 Non-small Cell Lung Cancers (NSCLC) with Mutations in BRAF, 557
Renata Ferrarotto and George R. Simon
37 Prognostic and Predictive Biomarker Signatures, 564
Johannes R. Kratz and David M. Jablons
38 Brain Metastasis from Lung Cancer, 572
Ritsuko U. Komaki and Amol J. Ghia
Index, 591
Color plate section between pages 146 and 147
